Price $132.63 |
Market Cap
41.93B
|
Sector Health Care |
Div. Growth
8.20%
|
|
P/E
32.5
|
P/B
7.6
|
P/S
6.15
|
Dividend %
0.60%
|
|
P/CF
312.5
|
P/FCF
53.2
|
Op. Cash Flow
1.35M
|
FCF
2.7
|
|
Op. Margin
24.10%
|
Net Margin
19.10%
|
ROE
25.00%
|
ROI
16.90%
|
|
ROA
12.50%
|
EPS Growth
11.60%
|
Current Ratio
2.0
|
Debt/Equity
51.50%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Biomerica Inc (BMRA) | $1.87 | - | - | 37.5M | Strong Buy |
| Applied DNA Sciences Inc (APDN) | $1.10 | - | - | 17.7M | Strong Buy |
| Cidara Therapeutics Inc (CDTX) | $1.19 | - | - | 129.6M | Strong Buy |
| Anika Therapeutics Inc (ANIK) | $28.12 | - | - | 459.3M | Strong Buy |
| AngioDynamics, Inc. (ANGO) | $12.40 | - | - | 495M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
